RAPT
RAPT
NASDAQ · Biotechnology

Rapt Therapeutics Inc

$58.02
+0.04 (+0.07%)
As of Mar 22, 10:07 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target -54.6% upside
Low Target $18.77
Average Target $26.34
High Target $31.12
Current Price $58.02
Current
$58.02
Target
$26.34
$18.77 $26.34 avg $31.12
Scenario Analysis
Bear Case
$18.77
-67.6%
Low target
Base Case
$26.34
-54.6%
Avg target
Bull Case
$31.12
+-46.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$57.88
0.2% from high
52-Week Low
$5.66
+925.1% from low
Target vs 52W High
$26.34
-54.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%